SOD1 and amyotrophic lateral sclerosis: The G93A ALS model has a mutant form of SOD-1; the earliest site of abnormal immune-mediated disease activity associated with this molecule is within the axonic processes and damage associated with the molecule is mediated by blood-derived macrophages [12,13].